With a market cap of $40.2 billion, Microchip Technology Incorporated (MCHP) is a global provider of smart, connected, and secure embedded control solutions, operating across the Americas, Europe, and Asia. It designs and manufactures a wide range of semiconductor products, including microcontrollers, microprocessors, analog devices, memory solutions, and specialized technologies for diverse industrial, automotive, and communication applications.
The Chandler, Arizona-based company is slated to announce its fiscal Q2 2027 results after the market closes on Nov. 5. Ahead of the release, analysts predict MCHP to report adjusted EPS of $0.82, a 215.4% jump from $0.26 in the year-ago quarter. It has exceeded or met Wall Street's earnings expectations in three of the past four quarters while missing on another occasion.
For fiscal 2027, analysts expect the chipmaker to report adjusted EPS of $3.20, a surge of 175.9% from $1.16 in fiscal 2026.
Shares of Microchip Technology have risen 18.2% over the past 52 weeks, outpacing the broader S&P 500 Index's ($SPX) 13% gain. However, the stock has lagged behind the State Street Technology Select Sector SPDR ETF's (XLK) 26.1% increase over the same period.
Microchip Technology shares soared 13.9% following its Q1 2027 results on Aug. 6, as quarterly revenue reached $1.49 billion and adjusted EPS of $0.76, beating analysts’ estimates. The rally was further fueled by an upbeat Q2 forecast, with revenue projected at $1.59 billion - $1.62 billion and adjusted EPS of $0.91 - $0.95. The stronger outlook reflected recovering demand across industrial and automotive markets, rising demand for chips used in AI data centers, and robust aerospace and defense spending amid geopolitical tensions.
Analysts' consensus view on MCHP stock remains bullish, with a "Strong Buy" rating overall. Out of 25 analysts covering the stock, 18 recommend a "Strong Buy," one "Moderate Buy," and six "Holds." The average analyst price target is $108.72, indicating a potential upside of 42.9% from the current levels.